Tuttle Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Tuttle Capital Management, LLC

  • $10.3 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 20, 2021
SELL
$478.3 - $607.98 $820,284 - $1.04 Million
-1,715 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$544.75 - $658.21 $559,458 - $675,981
1,027 Added 149.27%
1,715 $960,000
Q2 2020

Aug 11, 2020
BUY
$493.32 - $643.92 $339,404 - $443,016
688 New
688 $429,000
Q2 2019

Jul 29, 2019
SELL
$299.6 - $414.82 $746,303 - $1.03 Million
-2,491 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$372.08 - $439.57 $926,851 - $1.09 Million
2,491 New
2,491 $1.02 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Tuttle Capital Management, LLC Portfolio

Follow Tuttle Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tuttle Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email